NCT03641755 2026-02-23
Olaparib + Sapacitabine in BRCA Mutant Breast Cancer
Dana-Farber Cancer Institute
Phase 1 Active not recruiting
Clinical Trials
3 trialsNCT00999401 2021-12-22
A Study of Oral Sapacitabine and Oral Seliciclib in Patients With Advanced Solid Tumors
Cyclacel Pharmaceuticals, Inc.
Phase 1 Completed
NCT00380653 2021-12-13
Safety and Pharmacology Study of Sapacitabine to Treat Advanced Leukemias or Myelodysplastic Syndromes
Cyclacel Pharmaceuticals, Inc.
Phase 1 Completed